STAT3 and neoplasm: Treatment of CEP-701, a TKI, resistant-MV4-11 cell line with azacitidine, resulted in re-expression of SHP-1, a tumor suppressor gene and negative regulator of STAT3, leading to suppression of STAT3 and induction of apoptosis [106].